UNITED THERAPEUTICS Corp (UTHR) insider trading
Every open-market stock purchase and sale by UNITED THERAPEUTICS Corp executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Martine A Rothblatt (CEO) and 3 others sold $326M in the last 90 days.
- Last insider buy: Martine A Rothblatt (CEO), $864K, 4 months ago.
Last 12 months: insiders bought $864K (1 buy) and sold $1.4B (285 sales). Last close $475.45 on Sep 25, 2026.
Recent UTHR insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 1, 2026 | Paul A Mahon (VP) | Sold | $833K |
| Oct 1, 2026 | Paul A Mahon (VP) | Sold | $491K |
| Oct 1, 2026 | Paul A Mahon (VP) | Sold | $478K |
| Oct 1, 2026 | Paul A Mahon (VP) | Sold | $471K |
| Oct 1, 2026 | Paul A Mahon (VP) | Sold | $438K |
| Oct 1, 2026 | Paul A Mahon (VP) | Sold | $421K |
| Oct 1, 2026 | Paul A Mahon (VP) | Sold | $409K |
| Oct 1, 2026 | Paul A Mahon (VP) | Sold | $227K |
| Oct 1, 2026 | Paul A Mahon (VP) | Sold | $91.7K |
| Oct 1, 2026 | Paul A Mahon (VP) | Bought (not open market) | — |
| Sep 30, 2026 | Martine A Rothblatt (CEO) | Sold | $502K |
| Sep 30, 2026 | Martine A Rothblatt (CEO) | Sold | $457K |
| Sep 30, 2026 | Martine A Rothblatt (CEO) | Sold | $358K |
| Sep 30, 2026 | Martine A Rothblatt (CEO) | Sold | $326K |
| Sep 30, 2026 | Martine A Rothblatt (CEO) | Sold | $314K |
| Sep 30, 2026 | Martine A Rothblatt (CEO) | Sold | $311K |
| Sep 30, 2026 | Martine A Rothblatt (CEO) | Sold | $289K |
| Sep 30, 2026 | Martine A Rothblatt (CEO) | Sold | $260K |
| Sep 30, 2026 | Martine A Rothblatt (CEO) | Sold | $220K |
| Sep 30, 2026 | Martine A Rothblatt (CEO) | Sold | $197K |
| Sep 30, 2026 | Martine A Rothblatt (CEO) | Sold | $172K |
| Sep 30, 2026 | Martine A Rothblatt (CEO) | Sold | $154K |
| Sep 30, 2026 | Martine A Rothblatt (CEO) | Sold | $132K |
| Sep 30, 2026 | Martine A Rothblatt (CEO) | Sold | $115K |
| Sep 30, 2026 | Martine A Rothblatt (CEO) | Sold | $108K |
Who's trading UTHR
- Paul A Mahon, VP: sold $113M (200 sales), last Oct 1, 2026
- Martine A Rothblatt, CEO: bought $864K (1 buy), sold $838M (1721 sales), last Sep 30, 2026
- Nilda Mesa, Insider: sold $356K (4 sales), last Sep 14, 2026
- Richard Giltner, Insider: other filings, last Jul 22, 2026
- Ray Kurzweil, Insider: sold $2.4M (1 sale), last Jul 22, 2026
- Kevin Tracey, Insider: other filings, last Jul 22, 2026
- Christopher Causey, Insider: sold $2.3M (5 sales), last Jul 22, 2026
- Victor J Dzau, Insider: other filings, last Jul 22, 2026
- Judy D. Olian, Insider: sold $417K (4 sales), last Jul 22, 2026
- Christopher Patusky, Insider: sold $2.7M (3 sales), last Jul 22, 2026
- Louis W Sullivan, Insider: sold $3M (2 sales), last Jul 22, 2026
- Tommy G Thompson, Insider: sold $2.5M (5 sales), last Jul 22, 2026
- Jan Malcolm, Insider: sold $373K (9 sales), last Jul 22, 2026
- Linda Maxwell, Insider: other filings, last Jul 22, 2026
- James Edgemond, CFO: sold $210M (370 sales), last Jun 22, 2026
Get free alerts when an insider at UNITED THERAPEUTICS Corp files a new trade →